Back to Results
First PageMeta Content
Genetics / Emerging technologies / Pharmacology / Cancer organizations / Bioinformatics / Personalized medicine / Full genome sequencing / Myriad Genetics / Pharmacogenomics / Medicine / Biology / Genomics


OPMN WATCHING BRIEF ISSUE 2 The Ontario Personalized Medicine Network (OPMN) is a recently formed working group whose objective is to provide insight and direction on how to best guide research and implementation of per
Add to Reading List

Document Date: 2013-07-03 15:24:43


Open Document

File Size: 459,31 KB

Share Result on Facebook

City

Toronto / /

Company

Blue Cross / Bridgehead International / Molecular Diagnostics / Thomson Reuters / Health Quality Ontario / Laboratory Genetic Services / P.S.A. / OPMN Current OPMN Membership Personalized Medicine Resources / the New York Times / Rna Diagnostics Inc. / Blue Shield Technology Evaluation Center Caroline Popper / Oracle / Sanofi Pasteur Ltd. / International Partnerships / New England Journal / Genomics Resources / Genome Canada / CrossDisorder Group / European Reimbursement Systems / MYRIAD GENETICS / /

Country

United Kingdom / United States / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

Lunenfeld Tannenbaum Research Institute / Western University / Institute of Health Policy / Juravinski Hospital / University of Western Ontario / Mount Sinai Hospital / University Health Network / Ontario Institute / Toronto’s Hospital / Laboratory Developed Tests / McMaster University / University of Waterloo / University of Toronto Amit Oza / Ontario Cancer Research Institute / DISPARATE VIEWS ON INCIDENTAL FINDINGS RECOMMENDATIONS The American College of Medical Genetics / University of California / University of Toronto Ron Carter / The Hospital / Europe Institute of Medicine / Samuel Lunenfeld Research Institute / University of Toronto Vasanthi Srinivasan / University of Toronto / Ontario Brain Institute / Ontario Genomics Institute / Cancer Institute Jack Gauldie / McGill University / Canadian College of Medical Geneticists / /

IndustryTerm

care for individuals undergoing breast cancer / formed working / medicine technologies / healthcare institutions / insurance / excellent protocols / Online Medicine / treatment of cancer / Cancer Care / treatment of advanced metastatic or unresectable melanoma / transformative technology / diagnostic tests and tools / biotechnology / population-wide screening tool / cancer treatment / healthcare / prostate cancer treatment / market-approved personalized medicine technologies / healthcare workers / healthcare system / personalized medicine technologies / Web Consortium / /

MedicalCondition

Canadian Partnership Against Cancer / ovarian cancer / clinical cancer / translational cancer / disorder / prostate cancer / breast cancer / unresectable melanoma / cancer / schizophrenia / complex diseases / diabetes / psychiatric disorders / diseases / different disorders / disorders / major depressive disorder / movement disorder / individuals undergoing breast cancer / complex infantile-onset movement disorder / orphan diseases / autism spectrum disorders / Psychological disorder / cancers / disease / certain familial cancers / attentiondeficit hyperactivity disorder / tumour / cardiovascular disease / same underlying disease / related disorders / impotence / bipolar disorder / /

MedicalTreatment

mastectomy / chemotherapy / counseling / /

Organization

Hospital for Sick Children / U.K. PHG Foundation / Ontario Genomics Institute / National Research Council / Division of Applied Molecular Oncology / Cancer Center / Lunenfeld Tannenbaum Research Institute / Nuffield Council on Bioethics / Samuel Lunenfeld Research Institute / Distinguished University / Princess Margaret Cancer Centre / McGill University / Department of Pathology and Molecular Medicine / Ontario Brain Institute / American Society of Clinical Oncology / The Ontario Personalized Medicine Network / Medicare / Long Term Care / Institute for Molecular Medicine and Health / Department of Medicine / U.S. SUPREME COURT / Association for Molecular Pathology / Ontario Ministry of Research / European Science Foundation / The American College / Cancer Quality Council of Ontario / Juravinski Hospital / Ontario government / Sunnybrook Health Sciences Centre / Molecular Oncology Advisory Committee / Ontario Ministry of Research and Innovation / Ministry of Health / Mount Sinai Hospital / Personalized Medicine Coalition / Faculty of Medicine / McMaster University / PHG Foundation / Margaret Cancer Centre / Canadian College of Medical Geneticists / University of Waterloo / Centre of Genomics and Policy / Cancer Care Ontario’s Molecular Oncology Advisory Committee / Global Alliance / Institute of Health Policy / Management and Evaluation / Institute for Clinical Evaluative Sciences / University of Western Ontario / Western University / Centre for Applied Genomics / Ontario Institute for Cancer Research / Ontario Cancer Institute / U.S. FOOD AND DRUG ADMINISTRATION / McLaughlin Centre / Europe Institute of Medicine / Vanderbilt University / University of California / Los Angeles / American Clinical Laboratory Association / Medicine Coalition / Assistant Deputy Minister / Health System Strategy and Policy Division / University of Toronto Vasanthi Srinivasan / Technology Strategy Board / Department of Human Genetics / University of Toronto / Department of Family & Community Medicine / Ontario Cancer Research Institute / Centre of Genomics and Policy at McGill University / /

Person

Jeffrey Weitz / Kathy Siminovitch / Tom Hudson / Bartha Knoppers / Rhonda Tannenbaum / Murray Krahn / Fiona Miller / Kathryn Deuchars / Caroline Popper / Allison Barr / Katherine Siminovitch / Amit Oza / Jill Davies / Suzanne Kamel-Reid / Sydney G. Frankfort / Frederick Lee / Steve Scherer / Stephen Scherer / Marie Knoppers / Minassian / Salim Yusuf / Ross Feldman / Mark Lievonen / Ron Carter / Margaret Hamburg / Philippe Walker / Dennis Slamon / Angelina Jolie / Brenda Gallie / Les Levin / Kathleen Wynne / Mark Poznansky / Peter Goodhand / Pierre Meulien / Margaret Piper / Fred Lee / Susan Garfield / Samuel Lunenfeld / /

Position

Professor of Medicine and Biochemistry / President / Vice President / Senior Investigator / Path Forward / Chief Scientific Officer / Professor of Medicine / Princess / Professor / President and Scientific Director / President and CEO / Managing Director / Executive / Chairperson / Associate Professor / Professor of Medicine / Director / Research Branch / Ontario Ministries / Director / Genetics Program / Vice President / Business Development / Director / Lumira / Head / Laboratory Genetics and Director / Senior Staff Physician / Professor of Medicine / Special Projects Manager / Director / Commissioner / Co-Chair / Senior Scientist / Premier / Director of Clinical & Translational Informatics / /

Product

Dabigatran / This / CFI-400945 / /

ProvinceOrState

California / Ontario / /

PublishedMedium

New York Times / the New York Times / New England Journal of Medicine / Cancer Research / /

Region

Western Ontario / /

TVStation

Knowledge Network / /

Technology

personalized medicine technologies / neuroscience / diagnostic tests / market-approved personalized medicine technologies / chemotherapy / treatment Technology / market-approved technologies / Bioinformatics / biotechnology / MRI / /

SocialTag